Fedegari Group, world leader in the production of solutions for sterile processes in the pharmaceutical sector, is consolidating its role in the Asian market with the opening of a new office in Hyderabad, India.
The new branch will support Fedegari long-term partner ACE Technologies and provide technical assistance to the many local customers who have been working with Fedegari process equipment for years.
Fedegari has been operating on the Indian market for over 15 years and collaborates with all the main bio/pharmaceutical companies on the Asian continent.
“Nowadays, India is one of the most important countries for the pharmaceutical market. It is estimated to reach a value of 50 billion dollars by 2025,” said Giuseppe Fedegari, President of the Fedegari Group. “Opening a new office in a country like India and being closer to our customers and partners is strategic for Fedegari. It will allow us to improve the quality of the service offered and leverage our capabilities to further develop our business.
In addition to the new office opened in India, Fedegari counts 7 companies worldwide: Albuzzano, Pavia (Headquarters and Tech Center), Switzerland (Lugano), Germany (Frankfurt), USA (with a Tech Center in Pennsylvania), Singapore, China (Shanghai) and Russia (Moscow).
Today, Fedegari Group operates globally in more than 100 countries and 90% of its turnover comes from foreign markets, especially from the Asian market (China, India and Indonesia), which represents about one third of total turnover.